thymoquinone has been researched along with ADDH in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbas, AN; Abdel-Sattar, SA; Abu-Elfotuh, K; Ahmed, YM; Alshanwani, AR; Atwa, AM; El-Din, MN; Hamdan, AME; Mahran, YF; Reda, E; Zaghlool, SS | 1 |
1 trial(s) available for thymoquinone and ADDH
| Article | Year |
|---|---|
The protective effect of thymoquinone or/and thymol against monosodium glutamate-induced attention-deficit/hyperactivity disorder (ADHD)-like behavior in rats: Modulation of Nrf2/HO-1, TLR4/NF-κB/NLRP3/caspase-1 and Wnt/β-Catenin signaling pathways in rat
Topics: Animals; Attention Deficit Disorder with Hyperactivity; bcl-2-Associated X Protein; beta Catenin; Brain-Derived Neurotrophic Factor; Calcium; Caspase 1; Dopamine; Glycogen Synthase Kinase 3 beta; Male; NF-E2-Related Factor 2; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Norepinephrine; Rats; RNA, Messenger; Saline Solution; Sodium Glutamate; Thymol; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Wnt Signaling Pathway | 2022 |